Compound Summary
Doxylamine succinate
Compound Information
Doxylamine succinate
Compound Name: | Doxylamine succinate |
Compound CID: | 11224 |
Synonyms: | Doxylamine succinate 562-10-7 Decapryn Doxylamine (succinate) Doxylamine succinate salt More... |
Iupac Name: | butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine |
InChI: | InChI=1S/C17H22N2O.C4H6O4/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16;5-3(6)1-2-4(7)8/h4-12H,13-14H2,1-3H3;1-2H2,(H,5,6)(H,7,8) |
InChIKey: | KBAUFVUYFNWQFM-UHFFFAOYSA-N |
Canonical Smiles: | CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O |
Isomeric Smiles: | CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O |
Molecular Weight: | 388.5 |
Molecular Formula: | C21H28N2O5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Doxylamine succinate
Molecular Weight: | 388.5 |
Molecular Formula: | C21H28N2O5 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 9 |
Heavy Atom Count: | 28 |
Complexity: | 369 |
Synonyms
Doxylamine succinate
| Doxylamine succinate | Doxylamine succinate |
|---|---|
Doxylamine succinate |
562-10-7 |
Decapryn |
Doxylamine (succinate) |
Doxylamine succinate salt |
Evigoa D |
A-H Injection |
Decapryn Succinate |
Unisom |
Doxylamine hydrogen succinate |
Doxylamine succinate (1:1) |
Alsadorm |
Mereprine |
Decapryn succinate (1:1) |
Doxy-sleep-aid |
MFCD00056168 |
Doxylamine succinate USP |
butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine |
MLS000028417 |
2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate (1:1) |
CHEBI:82461 |
C21H28N2O5 |
N,N-dimethyl-2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethanamine succinate |
NSC-74772 |
Gittalun |
Sedaplus |
SMR000058436 |
Decapryn (TN) |
DSSTox_CID_552 |
Hoggar N |
Doxylamine succinate (USP) |
Butanedioic acid, compd. with N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine (1:1) |
Butanedioic acid, compd. with N,N-dimethyl-2-1-phenyl-1-(2-pyridinyl)ethoxyethanamine (1:1) |
DSSTox_RID_75656 |
DSSTox_GSID_20552 |
Butanedioic acid, compd. withN,N-dimethyl-2-1-phenyl-1-(2-pyridinyl)ethoxyethanamine (1:1)OTHER CA INDEX NAMES:Ethanamine, N,N-dimethyl-2-1-phenyl-1-(2-pyridinyl)ethoxy-,butanedioate (1:1) |
N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine succinate |
Topcare sleep aid |
CCRIS 4811 |
SR-01000003036 |
EINECS 209-228-7 |
EQUALINE SLEEP AID |
NSC 74772 |
Doxylamine succinate liquid |
Safetussin |
AI3-23993 |
NCGC00017028-02 |
CAS-562-10-7 |
Prestwick_887 |
Dimethylaminoethoxy-methyl-benzyl-pyridine succinate |
2-Dimethylaminoethoxyphenylmethyl-2-picoline succinate |
Opera_ID_566 |
Phenyl2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether succinate |
2-(alpha-(2-Dimethylaminoethoxy)-alpha-methylbenzyl)pyridine succinate |
2-(alpha(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine succinate (1:1) |
alpha-(2-Dimethylaminoethoxy)-alpha-methyl-alpha-phenyl-2-picoline acid succinate |
Pyridine, succinate (1:1) |
MLS000758288 |
MLS001076141 |
MLS001424137 |
MLS002222274 |
SCHEMBL160443 |
SPECTRUM1500267 |
CHEMBL1200392 |
DTXSID7020552 |
HMS502K03 |
HMS1568E15 |
HMS1920K04 |
HMS2051F14 |
HMS2091B09 |
HMS2095E15 |
HMS2231G05 |
HMS3261E17 |
HMS3370K04 |
HMS3393F14 |
HMS3652H19 |
HMS3712E15 |
HMS3885D13 |
Pharmakon1600-01500267 |
BCP24067 |
HY-A0069 |
NSC74772 |
Tox21_113515 |
Tox21_202078 |
Tox21_302861 |
Tox21_500348 |
CCG-38929 |
NSC756752 |
s4240 |
AKOS025310916 |
Tox21_113515_1 |
AC-4487 |
CCG-101033 |
CS-3232 |
LP00348 |
NC00283 |
NSC-756752 |
Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-, butanedioate (1:1) |
Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-, succinate (1:1) |
NCGC00016140-02 |
NCGC00016140-03 |
NCGC00016140-04 |
NCGC00021147-11 |
NCGC00089789-03 |
NCGC00093785-01 |
NCGC00093785-02 |
NCGC00093785-03 |
NCGC00256517-01 |
NCGC00259627-01 |
NCGC00261033-01 |
AS-13661 |
Q835 |
AB0017830 |
DB-052868 |
EU-0100348 |
FT-0625595 |
FT-0667789 |
SW197008-4 |
WLN: T6NJ BX1&R&O2N1&1 &OV2VO |
C19414 |
D 3775 |
D-9200 |
D02327 |
D81886 |
J10070 |
SR-01000003036-2 |
SR-01000003036-6 |
SR-01000003036-9 |
(Dimethylamino)ethoxy-methyl-benzyl-pyridine succinate |
F2173-1155 |
(2-Dimethylamino)ethoxyphenylmethyl-2-picoline succinate |
2-a-2-(Dimethylamino)ethoxy-a-methylbenzylpyridine succinate |
Doxylamine Hydrogen Succinate 1.0 mg/ml in Methanol (as free base) |
butanedioic acid,N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine |
Doxylamine succinate, United States Pharmacopeia (USP) Reference Standard |
Phenyl2-pyridylmethyl-(.beta.-N,N-dimethylamino)ethyl ether succinate |
2-.alpha.-(2-Dimethylamino)ethoxy-.alpha.-methylbenzylpyridine succinate |
Butanedioic acid,N-dimethyl-2-1-phenyl-1-(2-pyridinyl)ethoxyethanamine (1:1) |
Doxylamine for system suitability, European Pharmacopoeia (EP) Reference Standard |
Doxylamine hydrogen succinate, European Pharmacopoeia (EP) Reference Standard |
Doxylamine Succinate, Pharmaceutical Secondary Standard; Certified Reference Material |
Doxylamine succinate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
Succinic acid, compd. with 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine (1:1) (8CI) |
Succinic acid, compd. with 2-.alpha.-2-(dimethylamino)ethoxy-.alpha.-methylbenzylpyridine (1:1) |
Experimental Data
Doxylamine succinate
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 4.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Doxylamine succinate
Statistics Data
Doxylamine succinate
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 4.000000000000000 | 1 | 1 |
Statistics Data Visualization
Doxylamine succinate
